[ Price : $8.95]
Akebia Therapeutics completes an End of Dispute Type A meeting with FDA that discussed the companys upcoming NDA resubmission for ...[ Price : $8.95]
Medtronic recalls its implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators with glassed fe...[ Price : $8.95]
Olympus recalls about 1,500 OES BronchoFiberscope BF Type devices after receiving complaints of endobronchial combustion during th...[ Price : $8.95]
Four drug stakeholders suggest changes to a draft FDA guidance on scientific considerations in pediatric drug development.[ Price : $8.95]
A Government Accountability Office report on the challenges of regenerative medicine therapies and technologies offers 11 policy o...[ Price : $8.95]
FDA accepts for review an Elevar Therapeutics NDA for rivoceranib, an oral tyrosine kinase inhibitor in combination with camrelizu...[ Price : $8.95]
FDA warns Mumbai, India-based Centaur Pharmaceuticals about CGMP deviations in its manufacturing of active pharmaceutical ingredie...[ Price : $8.95]
FDA warns San Jose, CA-based Outset Medical it is illegally marketing two medical devices associated with hemodialysis.